•
Jun 30, 2016

CRISPR Therapeutics Q2 2016 Earnings Report

Total Revenue
$795K
EPS
-$0.946
Previous year: -$0.66
+43.3%
Gross Profit
-$7.81M
Previous year: -$1.49M
+425.4%
Cash and Equivalents
$247M

CRISPR Therapeutics

CRISPR Therapeutics